Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yomara K Romero"'
Autor:
Ricardo Choque-Guevara, Astrid Poma-Acevedo, Ricardo Montesinos-Millán, Dora Rios-Matos, Kristel Gutiérrez-Manchay, Angela Montalvan-Avalos, Stefany Quiñones-Garcia, Maria de Grecia Cauti-Mendoza, Andres Agurto-Arteaga, Ingrid Ramirez-Ortiz, Manuel Criollo-Orozco, Edison Huaccachi-Gonzales, Yomara K Romero, Norma Perez-Martinez, Gisela Isasi-Rivas, Yacory Sernaque-Aguilar, Doris Villanueva-Pérez, Freddy Ygnacio, Katherine Vallejos-Sánchez, Manolo Fernández-Sánchez, Luis A Guevara-Sarmiento, Manolo Fernández-Díaz, Mirko Zimic, COVID-19 Working Group in Perú
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0269823 (2022)
COVID-19 pandemic has accelerated the development of vaccines against its etiologic agent, SARS-CoV-2. However, the emergence of new variants of the virus lead to the generation of new alternatives to improve the current sub-unit vaccines in developm
Externí odkaz:
https://doaj.org/article/b51b31835bb7495ea4f9074b8b477e35
Autor:
Holger Mayta, Yomara K Romero, Alejandra Pando, Manuela Verastegui, Freddy Tinajeros, Ricardo Bozo, Josephine Henderson-Frost, Rony Colanzi, Jorge Flores, Richard Lerner, Caryn Bern, Robert H Gilman, Chagas Working Group in Perú and Bolivia
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 13, Iss 1, p e0007024 (2019)
BackgroundThe detection of Trypanosoma cruzi genetic material in clinical samples is considered an important diagnostic tool for Chagas disease. We have previously demonstrated that PCR using clot samples yields greater sensitivity than either buffy
Externí odkaz:
https://doaj.org/article/a767b6931d194159a2d355b03b85b0a2
Autor:
Andres Agurto-Arteaga, Astrid Poma-Acevedo, Dora Rios-Matos, Ricardo Choque-Guevara, Ricardo Montesinos-Millán, Ángela Montalván, Gisela Isasi-Rivas, Yudith Cauna-Orocollo, María de Grecia Cauti-Mendoza, Norma Pérez-Martínez, Kristel Gutierrez-Manchay, Ingrid Ramirez-Ortiz, Dennis Núñez-Fernández, Mario I. Salguedo-Bohorquez, Stefany Quiñones-Garcia, Manolo Fernández Díaz, Luis A. Guevara Sarmiento, Mirko Zimic, COVID-19 Working Group in Perú, Ricardo Antiparra, Manuel Ardiles-Reyes, Katherine Calderón, Maria de Grecia Cauti-Mendoza, Naer Chipana-Flores, Xiomara Chunga-Girón, Manuel Criollo-Orozco, Lewis De La Cruz, Nicolás E. Delgado-Pease, Elmer Delgado-Ccancce, Christian Elugo-Guevara, Manolo Fernández-Díaz, Manolo Fernández-Sánchez, Luis Guevara-Sarmiento, Kristel Gutiérrez, Oscar Heredia-Almeyda, Edison Huaccachi-Gonzalez, Pedro Huerta-Roque, Eliana Icochea, Gabriel Jiménez-Avalos, Romina A. Juscamaita-Bartra, Abraham Licla-Inca, Angela Montalván, Adiana Ochoa-Ortiz, Gustavo E. Olivos-Ramirez, Erika Páucar-Montoro, Kathy Pauyac, Jose L. Perez-Martinez, Norma Pérez-M, Daniel Ramos-Sono, Angela A. Rios-Angulo, Aldo Rojas-Neyra, Yomara K. Romero, Yacory Sernaque-Aguilar, Patricia Sheen-Cortavarrı́a, Luis F. Soto, Luis Tataje-Lavanda, Julio Ticona, Katherine Vallejos-Sánchez, A. Paula Vargas-Ruiz, Doris Villanueva-Pérez, Freddy Ygnacio-Aguirre, Mirko Zimic-Peralta
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Within the framework of the current COVID-19 pandemic, there is a race against time to find therapies for the outbreak to be controlled. Since vaccines are still tedious to develop and partially available for low-income countries, passive immunity ba
Externí odkaz:
https://doaj.org/article/b87b2f7e669c4f6f8d6f5e8c60f85c40
Autor:
Ingrid Ramirez-Ortiz, Manuel Criollo-Orozco, Gisela Isasi-Rivas, Yacory Sernaque-Aguilar, Angela Montalvan, Andres Agurto-Arteaga, Luis Raez Guevara, Norma Perez-Martinez, Mirko Zimic, Maria de Grecia Cauti-Mendoza, Yomara K. Romero Lazaro, Dora Rios-Matos, Edison Huaccachi-Gonzales, Kristel Gutierrez-Manchay, Ricardo Choque-Guevara, Stefany Quinones-Garcia, Manolo Fernández-Díaz, Doris Villanueva-Perez, Ricardo Montesinos-Millan, Katherine Vallejos-Sánchez, Manolo Fernández-Sánchez, Astrid Poma-Acevedo
COVID-19 pandemic has accelerated the development of vaccines against its etiologic agent, SARS-CoV-2. However, the emergence of new variants of the virus requires new immunization strategies in addition to the current vaccines approved for human adm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33786fbfcf245428c86b15f9ea947ceb
https://doi.org/10.1101/2021.11.26.470043
https://doi.org/10.1101/2021.11.26.470043
Autor:
Alejandra Pando, Jorge Flores, Rony Colanzi, Manuela Verastegui, Yomara K. Romero, Bolivia, Freddy Tinajeros, Josephine Henderson-Frost, Ricardo Bozo, Robert H. Gilman, Caryn Bern, Richard Lerner, Holger Mayta
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 13, Iss 1, p e0007024 (2019)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Background The detection of Trypanosoma cruzi genetic material in clinical samples is considered an important diagnostic tool for Chagas disease. We have previously demonstrated that PCR using clot samples yields greater sensitivity than either buffy